Get Real Time Here
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals Stock (NASDAQ:OLMA), Quotes and News Summary
Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
| Open13.170 | Close12.350 |
| Vol / Avg.462.778K / 300.355K | Mkt Cap673.862M |
| Day Range11.860 - 13.170 | 52 Wk Range2.220 - 13.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.490 | 0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 16.00 | 19.00 |
| 2023-09-06 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 21.00 |
| 2023-09-05 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 22.00 | 28.00 |
| 2023-08-10 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 14.00 | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals | -4.85% | 673.9M |
| CABA | Cabaletta Bio | 0.13% | 605.8M |
| VALN | Valneva | 1.94% | 803.6M |
| AMAM | Ambrx Biopharma | 2.68% | 713.1M |
| CNTA | Centessa Pharmaceuticals | 3.54% | 627.3M |
How do I buy Olema Pharmaceuticals (OLMA) stock?
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Who are Olema Pharmaceuticals's (OLMA) competitors?
Other companies in Olema Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Ambrx Biopharma (NASDAQ:AMAM), Centessa Pharmaceuticals (NASDAQ:CNTA) and Genelux (NASDAQ:GNLX).
What is the target price for Olema Pharmaceuticals (OLMA) stock?
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by JP Morgan on Friday, September 15, 2023. The analyst firm set a price target for 19.00 expecting OLMA to rise to within 12 months (a possible 53.85% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Olema Pharmaceuticals (OLMA)?
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $12.35 last updated September 29, 2023 at 8:20 PM UTC.
Does Olema Pharmaceuticals (OLMA) pay a dividend?
There is no dividend information for Olema Pharmaceuticals.
When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?
Olema Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Olema Pharmaceuticals (OLMA) going to split?
There is no upcoming split for Olema Pharmaceuticals.
What sector and industry does Olema Pharmaceuticals (OLMA) operate in?
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.